PANTHERx is proud to join the Centene family of companies. Through this transaction, we are reaffirming our relentless commitment to transforming lives and removing barriers for individuals living with complex …
Today is a transformative day and the culmination of a great deal of effort and diligence to support the future of PANTHERx. We are very excited to announce that we …
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals, the leading RNAi therapeutics company, as a very limited distribution pharmacy partner …
Read the Official PANTHERx Press Release. Ernst & Young LLP (EY US) yesterday announced that Dr. Gordon J. Vanscoy, Chairman & CEO of both PANTHERx Rare and RareMed Solutions, was …
PANTHERx is pleased to announce the receipt of another Pittsburgh Business Times Best Places to Work Award, adding to a history of success. PANTHERx is not afraid to break molds, …
Smart Business Magazine has announced that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, was selected as a 2020 Smart 50 Award honoree. Since 2014, …
Ernst & Young LLP (EY US) announced today that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, was named a 2020 Entrepreneur of The Year® …
In May of 2020 PANTHERx Rare Pharmacy shared the news that we had been officially recognized as a prestigious US Best Managed Company for overall business performance and sustained growth. …
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Blueprint Medicines as a limited distribution partner for new drug GAVRETO™ (pralsetinib), which was …
PANTHERx Rare is proud to announce that it has been awarded a 2020 Top Workplaces by the Pittsburgh Post-Gazette. Awardees are determined by associate feedback to an anonymous survey facilitated …
